Septicemia
Also known as: Septicaemia / Septicemia (disorder) / Systemic infection (disorder) / [X]Septicemia, unspecified (disorder) / Toxemia (disorder) / Unspecified septicaemia / Unspecified septicemia / Septicemia NOS / Septicaemia NOS / Septicemia NOS (disorder) / (Septicaemia NOS) or (sepsis) / Infection systemic / Infectious systemic inflammatory response syndrome (disorder) / Systemic infection / Sepsis / Sepsis NOS
Drug | Drug Name | Drug Description |
---|---|---|
DB00415 | Ampicillin | A penicillin derivative used for the treatment of a variety of infections caused by gram-positive and gram-negative bacteria as well as some anaerobes. |
DB00355 | Aztreonam | A beta-lactam antibiotic used to treat select aztreonam sensitive gram negative bacteria. |
DB01331 | Cefoxitin | A semi-synthetic, broad-spectrum antibiotic for parenteral administration used for the treatment of serious bacterial infections, such as urinary tract infection, blood infection, bone and joint infection, and lower respiratory tract infection. |
DB01112 | Cefuroxime | A cephalosporin indicated for the treatment of a variety of infections including acute bacterial otitis media, several upper respiratory tract infections, skin infections, urinary tract infections, gonorrhea, early Lyme disease, and impetigo. |
DB00766 | Clavulanic acid | A beta lactamase inhibitor used to enhance the effectiveness of beta lactam antibiotics. |
DB01099 | Flucytosine | An antifungal indicated only to treat severe infections throughout the body caused by susceptible strains of Candida or Cryptococcus. |
DB00319 | Piperacillin | A penicillin antibiotic combined with tazobactam to treat piperacillin-resistant, piperacillin/tazobactam susceptible, β-lactamase generating strains of several bacteria. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00760 | Meropenem | 1 / 2 | Enrolling by Invitation | 1 |
DB04933 | Eritoran | 2 | Completed | 1 |
DB12768 | BCG vaccine | 3 | Recruiting | 1 |
DB10061 | Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | 3 | Completed | 1 |
DB13889 | Meningococcal polysaccharide vaccine group A | 3 | Completed | 1 |
DB13890 | Meningococcal polysaccharide vaccine group C | 3 | Completed | 1 |
DB13887 | Meningococcal polysaccharide vaccine group W-135 | 3 | Completed | 1 |
DB13888 | Meningococcal polysaccharide vaccine group Y | 3 | Completed | 1 |
DB00878 | Chlorhexidine | 4 | Unknown Status | 1 |
DB10061 | Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | 4 | Completed | 1 |
DB13889 | Meningococcal polysaccharide vaccine group A | 4 | Completed | 1 |
DB13890 | Meningococcal polysaccharide vaccine group C | 4 | Completed | 1 |
DB13887 | Meningococcal polysaccharide vaccine group W-135 | 4 | Completed | 1 |
DB13888 | Meningococcal polysaccharide vaccine group Y | 4 | Completed | 1 |